Published in J Appl Physiol (1985) on December 30, 2010
AKT signalling in the failing heart. Eur J Heart Fail (2011) 1.41
Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle (2015) 1.05
Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovasc Res (2014) 0.98
Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS One (2012) 0.98
Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? Heart Fail Rev (2012) 0.92
Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats. Nutrients (2012) 0.91
Temporal changes in magnetic resonance imaging in the mdx mouse. BMC Res Notes (2013) 0.91
Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction. Circ Heart Fail (2011) 0.89
Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs. Tissue Eng Part A (2014) 0.89
Skeletal muscle protein metabolism in human heart failure. Curr Opin Clin Nutr Metab Care (2013) 0.81
Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis. J Biol Chem (2013) 0.79
Optimal homeostasis necessitates bistable control. J R Soc Interface (2012) 0.79
Muscle RING finger-1 promotes a maladaptive phenotype in chronic hypoxia-induced right ventricular remodeling. PLoS One (2014) 0.77
Does a reduction in anabolic signaling contribute to muscle wasting in chronic heart failure? J Appl Physiol (1985) (2011) 0.76
Molecular mechanism of sarcopenia and cachexia: recent research advances. Pflugers Arch (2017) 0.76
AKT/PKB signaling: navigating downstream. Cell (2007) 31.26
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell (2008) 16.72
Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J (1996) 16.68
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell (2006) 11.48
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell (2006) 10.50
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev (2002) 8.31
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol (2001) 6.71
Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab (2008) 4.91
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation (1991) 4.89
Reversal of catabolism by beta-blockade after severe burns. N Engl J Med (2001) 4.02
Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr (1990) 3.24
The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc (2002) 2.65
Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol (2004) 2.58
Examination of data normalization procedures for expressing peak VO2 data. J Appl Physiol (1985) (1993) 2.35
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest (2005) 2.24
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol (1997) 2.19
The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol (2003) 2.15
Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res (2005) 2.12
Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol (2002) 2.09
Quantitative determination of myosin and actin in rabbit skeletal muscle. J Mol Biol (1983) 2.04
Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest (1999) 2.00
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem (2004) 1.89
Functionally relevant thresholds of quadriceps femoris strength. J Gerontol A Biol Sci Med Sci (2002) 1.80
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol (1985) (2007) 1.76
The Framingham Disability Study: relationship of various coronary heart disease manifestations to disability in older persons living in the community. Am J Public Health (1990) 1.70
Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol (2006) 1.66
Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J (2009) 1.60
Effects of congestive heart failure on Ca2+ handling in skeletal muscle during fatigue. Circ Res (2006) 1.57
Cardiac disability. The impact of coronary heart disease on patients' daily activities. Arch Intern Med (1985) 1.50
Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers. J Appl Physiol (1985) (2000) 1.44
Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res (2008) 1.44
Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Diabetes (2003) 1.42
Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol (1999) 1.39
Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int J Biochem Cell Biol (2005) 1.38
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J (2006) 1.31
Muscle fiber type specificity in insulin signal transduction. Am J Physiol (1999) 1.25
Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol (2002) 1.22
Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats. Am J Physiol Heart Circ Physiol (2007) 1.20
Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. Am J Physiol Endocrinol Metab (2002) 1.20
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol (1998) 1.19
The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol (2003) 1.19
Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol (2010) 1.17
Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function. Circ Heart Fail (2009) 1.13
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Resistance training on physical performance in disabled older female cardiac patients. Med Sci Sports Exerc (2003) 1.04
Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Basic Res Cardiol (2003) 1.04
Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol Endocrinol Metab (2004) 1.03
Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve (2009) 1.02
Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure. Eur Heart J (1997) 0.96
Resistance training increases total daily energy expenditure in disabled older women with coronary heart disease. J Appl Physiol (1985) (2005) 0.95
Daily energy expenditure in free-living heart failure patients. Am J Physiol (1997) 0.93
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol (2003) 0.92
Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol (1985) (2005) 0.86
Insulin signalling and resistance in patients with chronic heart failure. J Physiol (2003) 0.82
Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74
A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development (2004) 3.97
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.63
Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation (2013) 2.82
Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation (2002) 2.46
Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol (2009) 2.45
Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation (2011) 2.05
Chlamydomonas IFT172 is encoded by FLA11, interacts with CrEB1, and regulates IFT at the flagellar tip. Curr Biol (2005) 1.68
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci (2008) 1.60
Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro. J Mol Cell Cardiol (2009) 1.57
A re-examination of the metabolic equivalent concept in individuals with coronary heart disease. J Cardiopulm Rehabil Prev (2007) 1.54
Costs and benefits of transforming primary care practices: a qualitative study of North Carolina's Improving Performance in Practice. J Healthc Manag (2014) 1.47
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail (2012) 1.46
Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J (2006) 1.45
Gender alters the high-density lipoprotein cholesterol response to cardiac rehabilitation. J Cardiopulm Rehabil (2004) 1.44
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation. Clin Sci (Lond) (2010) 1.44
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail (2012) 1.43
Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain. J Mol Cell Cardiol (2011) 1.40
Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg (2008) 1.36
Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac Soc (2009) 1.31
Direct interactions of intraflagellar transport complex B proteins IFT88, IFT52, and IFT46. J Biol Chem (2010) 1.31
Two-state model of acto-myosin attachment-detachment predicts C-process of sinusoidal analysis. Biophys J (2007) 1.29
The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care (2005) 1.27
c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.26
Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A (2003) 1.25
The obesity paradox: perception vs knowledge. Mayo Clin Proc (2010) 1.20
DNA damage and breast cancer risk. Carcinogenesis (2003) 1.19
Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol (2010) 1.17
Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J (2008) 1.15
Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function. Circ Heart Fail (2009) 1.13
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Effects of resistance training on physical function in older disabled women with coronary heart disease. J Appl Physiol (1985) (2002) 1.12
Subunit interactions and organization of the Chlamydomonas reinhardtii intraflagellar transport complex A proteins. J Biol Chem (2011) 1.11
Geographic distribution of cardiac rehabilitation programs in the United States. J Cardiopulm Rehabil (2005) 1.10
Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol (2005) 1.08
Changing clinical profile of patients entering cardiac rehabilitation/secondary prevention programs: 1996 to 2006. J Cardiopulm Rehabil Prev (2008) 1.04
Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am J Physiol Heart Circ Physiol (2008) 1.03
Facilitators of transforming primary care: a look under the hood at practice leadership. Ann Fam Med (2013) 1.03
Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels. J Physiol (2011) 1.03
Cardiac rehabilitation participation in underserved populations. Minorities, low socioeconomic, and rural residents. J Cardiopulm Rehabil Prev (2011) 1.02
Phosphorylation and the N-terminal extension of the regulatory light chain help orient and align the myosin heads in Drosophila flight muscle. J Struct Biol (2009) 0.99
Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs. Am Heart J (2005) 0.99
Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients. Am Heart J (2003) 0.98
Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol (1985) (2013) 0.98
Paramyosin phosphorylation site disruption affects indirect flight muscle stiffness and power generation in Drosophila melanogaster. Proc Natl Acad Sci U S A (2005) 0.97
Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc (2011) 0.96
Effects of endurance and resistance training on total daily energy expenditure in young women: a controlled randomized trial. J Clin Endocrinol Metab (2002) 0.96
Cardiac myosin isoforms exhibit differential rates of MgADP release and MgATP binding detected by myocardial viscoelasticity. J Mol Cell Cardiol (2012) 0.95
Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics. J Appl Physiol (1985) (2013) 0.92
Left ventricular end-diastolic volume is normal in patients with heart failure and a normal ejection fraction: a renewed consensus in diastolic heart failure. J Am Coll Cardiol (2007) 0.92
Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells. Am J Respir Cell Mol Biol (2012) 0.91
Activation of the glutaredoxin-1 gene by nuclear factor κB enhances signaling. Free Radic Biol Med (2011) 0.90
Exercise-based cardiac rehabilitation for very old patients (> or =75 years): focus on physical function. J Cardiopulm Rehabil Prev (2008) 0.90
Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women? Metabolism (2003) 0.89
Intracellular distributions of essential elements in cardiomyocytes. J Struct Biol (2006) 0.89
Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J Appl Physiol (1985) (2012) 0.88
Handgrip strength in cardiac rehabilitation: normative values, interaction with physical function, and response to training. J Cardiopulm Rehabil Prev (2007) 0.88
Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity. Exp Hematol (2004) 0.87
Failure to improve cardiopulmonary fitness in cardiac rehabilitation. J Cardiopulm Rehabil Prev (2009) 0.87
Thick-to-thin filament surface distance modulates cross-bridge kinetics in Drosophila flight muscle. Biophys J (2012) 0.86
Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med (2007) 0.86
Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol (1985) (2005) 0.86
Clinical research in cardiac rehabilitation and secondary prevention: looking back and moving forward. J Cardiopulm Rehabil Prev (2011) 0.86
The obesity epidemic in the United States: role of cardiac rehabilitation. Coron Artery Dis (2006) 0.85
More extensive implementation of the chronic care model is associated with better lipid control in diabetes. J Am Board Fam Med (2014) 0.85
Titin: an endosarcomeric protein that modulates myocardial stiffness in DCM. J Card Fail (2002) 0.85
Myofilament remodeling during the progression of heart failure. J Card Fail (2002) 0.85
Core competencies for cardiac rehabilitation/secondary prevention professionals: 2010 update: position statement of the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev (2011) 0.84
Age-related differences in metabolic adaptations following resistance training in women. Exp Gerontol (2004) 0.84
Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease. Ann N Y Acad Sci (2010) 0.84
Skeletal muscle contractile protein function is preserved in human heart failure. J Appl Physiol (1985) (2008) 0.84
Pedometer step counts predict cardiac risk factors at entry to cardiac rehabilitation. J Cardiopulm Rehabil Prev (2008) 0.83
Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB. Am J Physiol Heart Circ Physiol (2007) 0.82
Passive stiffness in Drosophila indirect flight muscle reduced by disrupting paramyosin phosphorylation, but not by embryonic myosin S2 hinge substitution. Biophys J (2006) 0.82
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer. Carcinogenesis (2011) 0.82
COOH-terminal truncation of flightin decreases myofilament lattice organization, cross-bridge binding, and power output in Drosophila indirect flight muscle. Am J Physiol Cell Physiol (2011) 0.81
Elevated rates of force development and MgATP binding in F764L and S532P myosin mutations causing dilated cardiomyopathy. J Mol Cell Cardiol (2013) 0.81
Weight reduction in the cardiac rehabilitation setting. J Cardiopulm Rehabil (2002) 0.81
Acto-myosin crossbridge kinetics in humans with coronary artery disease: influence of sex and diabetes mellitus. J Mol Cell Cardiol (2005) 0.80
Outcomes and adverse events among patients with implantable cardiac defibrillators in cardiac rehabilitation: a case-controlled study. J Cardiopulm Rehabil Prev (2009) 0.80
Coronary venous capture of contrast during angiography. J Interv Cardiol (2006) 0.80
Effect of exercise training and weight loss on platelet reactivity in overweight patients with coronary artery disease. J Cardiopulm Rehabil Prev (2013) 0.80
Cardiac Rehabilitation After Heart Valve Surgery: COMPARISON WITH CORONARY ARTERY BYPASS GRAFT PATIENTS. J Cardiopulm Rehabil Prev (2015) 0.79
Effect of a computerized referral at hospital discharge on cardiac rehabilitation participation rates. J Cardiopulm Rehabil Prev (2009) 0.79
An inverse power-law distribution of molecular bond lifetimes predicts fractional derivative viscoelasticity in biological tissue. Biophys J (2013) 0.79
Accelerated decline of aerobic fitness with healthy aging: what is the good news? Circulation (2005) 0.79
Impact of cardiovascular fitness and physical activity level on health outcomes in older persons. Mech Ageing Dev (2003) 0.78
Incorporating patients with chronic heart failure into outpatient cardiac rehabilitation: practical recommendations for exercise and self-care counseling-a clinical review. J Cardiopulm Rehabil Prev (2014) 0.78